| abstract |
Compounds of the general formula wherein R 1 is C 5,6-cycloalkyl substituted with CF 3, lower alkyl, - (CH 2) nOH, - (CH 2) n -O-lower alkyl or is 1-bicyclo [2,2,1] hept. 2-yl, 1- (7-oxa-bicyclo [2,2,1] hept-2-yl, 1- (5-exo-hydroxy-bicyclo [2,2,1] hept-2-exo-yl, 1- (5-Exo-hydroxy-bicyclo [2,2,1] hept-2-endo-yl, or is 1-adamantan-1-yl; R 2 is lower alkyl; or R 1 and R 2 together with the N atom form the group of 8-oxa-3-aza-bicyclo [3,2,1] octane; n is 0 or 1; and pharmaceutically acceptable acid addition salts thereof for the treatment of and pharmaceutically acceptable acid addition salts thereof for the treatment of diseases related to the A2A receptor. |